Buy Regeneron Pharmaceuticals Stock | REGN Stock Price & Latest News | Public.com
REGN

Regeneron Pharmaceuticals

$0.00 (0.00%)Today
    View Regeneron Pharmaceuticals (REGN) stock trends here

    About REGN

    Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    17.57
    11.71
    5.86
    0
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    $17.57

    Actual EPS
    Q2 2021

    Stats

    Market Cap$52,91B
    Volume508,77k
    Price-to-Earnings Ratio16.19
    Dividend Rate
    Dividend Yield
    1 Year High$664.64
    1 Year Low$441.00
    Open$498.50
    High$502.90
    Low$492.81

    Buy any stock with any amount of money.

    Download the App
    Download the app